health
National Day Against Lymphoma
On the occasion of the National Day Against Lymphoma 2026, a gathering was held in Belgrade organized by the LIPA Association of Lymphoma Patients, which highlighted the importance of early detection of this group of malignant diseases, timely recognition of symptoms, and adequate and accessible treatment.
TL;DR
- An event in Belgrade on National Day Against Lymphoma emphasized early detection, symptom recognition, and adequate treatment.
- Diffuse large B-cell lymphoma (DLBCL), an aggressive non-Hodgkin lymphoma, was the focus, often diagnosed late and with a short survival rate if untreated.
- In 2024, approximately 400 DLBCL cases were diagnosed in Serbia, with 230 deaths.
- Experts stressed that early detection and timely therapy significantly increase cure rates, while innovative treatments, though available in modern medicine, are not systematically accessible in Serbia.
- Maja Marković from the LIPA Association noted that innovative drugs for DLBCL have not been added to the Serbian drug list for over 20 years.
- DLBCL can manifest with enlarged lymph nodes and symptoms mimicking infections, often leading to late diagnosis.
- While standard therapy works for about 50% of patients, innovative treatments are recommended for others but are not widely available.
- Successful treatment provides social benefits by reducing healthcare costs and allowing patients to return to daily life.